JP2024537323A5 - - Google Patents
Info
- Publication number
- JP2024537323A5 JP2024537323A5 JP2024522070A JP2024522070A JP2024537323A5 JP 2024537323 A5 JP2024537323 A5 JP 2024537323A5 JP 2024522070 A JP2024522070 A JP 2024522070A JP 2024522070 A JP2024522070 A JP 2024522070A JP 2024537323 A5 JP2024537323 A5 JP 2024537323A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025006663A JP2025061426A (ja) | 2021-10-15 | 2025-01-17 | 抗グリピカン3抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/124182 | 2021-10-15 | ||
| CN2021124182 | 2021-10-15 | ||
| PCT/CN2022/125725 WO2023061505A1 (en) | 2021-10-15 | 2022-10-17 | Anti-glypican 3 antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025006663A Division JP2025061426A (ja) | 2021-10-15 | 2025-01-17 | 抗グリピカン3抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537323A JP2024537323A (ja) | 2024-10-10 |
| JP2024537323A5 true JP2024537323A5 (cg-RX-API-DMAC7.html) | 2025-11-10 |
Family
ID=85988149
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522070A Pending JP2024537323A (ja) | 2021-10-15 | 2022-10-17 | 抗グリピカン3抗体 |
| JP2025006663A Pending JP2025061426A (ja) | 2021-10-15 | 2025-01-17 | 抗グリピカン3抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025006663A Pending JP2025061426A (ja) | 2021-10-15 | 2025-01-17 | 抗グリピカン3抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20240409663A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4527465A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024537323A (cg-RX-API-DMAC7.html) |
| CN (3) | CN118488970A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023061505A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024061305A1 (zh) * | 2022-09-22 | 2024-03-28 | 上海美雅珂生物技术有限责任公司 | Gpc3抗体药物偶联物及其应用 |
| CN119894935B (zh) * | 2022-09-30 | 2026-06-19 | 信立泰(成都)生物技术有限公司 | 抗gpc3单克隆抗体/双特异性抗体或其抗原结合片段及其用途 |
| WO2025045242A1 (zh) * | 2023-09-01 | 2025-03-06 | 信立泰(成都)生物技术有限公司 | 一种靶向gpc3的双特异性抗体或抗原结合片段及其用途 |
| EP4775226A1 (en) * | 2023-09-05 | 2026-07-15 | Lepu Biopharma Co., Ltd. | Antibody drug conjugate targeting gpc3 and use thereof |
| KR20250116580A (ko) * | 2024-01-24 | 2025-08-01 | 국립암센터 | Gpc3에 특이적으로 결합하는 신규 항체를 이용한 키메라 항원 수용체 t 세포 |
| WO2026016998A1 (zh) * | 2024-07-15 | 2026-01-22 | 北京剂泰医药科技有限公司 | 编码针对GPC3和CD3双特异性抗体的mRNA分子 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6130364A (en) | 1995-03-29 | 2000-10-10 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| US6420140B1 (en) | 1996-10-11 | 2002-07-16 | Abgenix, Inc. | Production of multimeric protein by cell fusion method |
| EP1411118B1 (en) * | 2001-06-22 | 2008-09-03 | Chugai Seiyaku Kabushiki Kaisha | Cell proliferation inhibitors containing anti-glypican-3 antibody |
| WO2004022597A1 (ja) * | 2002-09-04 | 2004-03-18 | Chugai Seiyaku Kabushiki Kaisha | Gpc3の血中可溶化n端ペプチドに対する抗体 |
| AU2005256113B2 (en) * | 2004-07-09 | 2011-02-10 | Chugai Seiyaku Kabushiki Kaisha | Anti-glypican 3 antibody |
| AU2008275985B2 (en) * | 2007-07-17 | 2013-09-19 | E. R. Squibb & Sons, L.L.C. | Monoclonal antibodies against Glypican-3 |
| CN101633693A (zh) * | 2009-08-24 | 2010-01-27 | 中国人民解放军第二军医大学 | 一种抗gpc3的单克隆抗体 |
| JP2017522861A (ja) * | 2014-05-22 | 2017-08-17 | ジェネンテック, インコーポレイテッド | 抗gpc3抗体及びイムノコンジュゲート |
| US9926377B2 (en) * | 2014-05-22 | 2018-03-27 | Genentech, Inc. | Anti-GPC3 antibodies and immunoconjugates |
| CN105037540A (zh) * | 2015-05-13 | 2015-11-11 | 北京比洋生物技术有限公司 | 抗磷脂酰肌醇蛋白聚糖3全人源抗体 |
| AU2016304060B2 (en) * | 2015-08-03 | 2022-09-29 | Crage Medical Co., Limited | Antibody against glypican-3 and application thereof |
| CN109153719B (zh) * | 2016-03-15 | 2022-12-30 | 中外制药株式会社 | 使用pd-1轴结合拮抗剂和抗gpc3抗体治疗癌症的方法 |
| EP3615574B1 (en) * | 2017-04-26 | 2026-06-24 | Eureka Therapeutics, Inc. | Constructs specifically recognizing glypican 3 and uses thereof |
| CN109988240B (zh) * | 2017-12-29 | 2022-06-28 | 安源医药科技(上海)有限公司 | 抗gpc-3抗体及其用途 |
| CN109021108B (zh) * | 2018-08-27 | 2019-06-25 | 南京医科大学 | 抗gpc3全人源化抗体、其嵌合抗原受体细胞及应用 |
| CN114340671A (zh) * | 2019-08-01 | 2022-04-12 | R.P.谢勒技术有限责任公司 | 对gpc3特异性的抗体及其使用方法 |
| JP2025006663A (ja) * | 2023-06-29 | 2025-01-17 | 積水化学工業株式会社 | 情報処理システム、情報処理方法及びプログラム |
-
2022
- 2022-10-17 CN CN202280083725.4A patent/CN118488970A/zh active Pending
- 2022-10-17 CN CN202411431728.XA patent/CN119080937A/zh active Pending
- 2022-10-17 JP JP2024522070A patent/JP2024537323A/ja active Pending
- 2022-10-17 EP EP25152478.1A patent/EP4527465A3/en active Pending
- 2022-10-17 WO PCT/CN2022/125725 patent/WO2023061505A1/en not_active Ceased
- 2022-10-17 US US18/700,228 patent/US20240409663A1/en active Pending
- 2022-10-17 CN CN202411431725.6A patent/CN118994403B/zh active Active
- 2022-10-17 EP EP22880441.5A patent/EP4416187A1/en active Pending
-
2025
- 2025-01-16 US US19/026,082 patent/US20250154280A1/en active Pending
- 2025-01-17 JP JP2025006663A patent/JP2025061426A/ja active Pending